Product Information

VARENICLINE 1 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.3544 per EA under NDC 60687064821. Its NADAC has been published 243 times since Mar 9, 2022.

FDA first approved this application on Aug 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the varenicline tartrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

VARENICLINE 1 MG TABLET

varenicline tartrate
$0.3544per EA
Discontinued
Low Outlier

Strength

1 mg/1

NDC

60687064821

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

VARENICLINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA201785

FDA Approved

8/11/2021

TE Code

AB

On Market Since

2/11/2022

Pharmacological Classes

Cholinergic Agonists
Cholinergic Receptor Agonist
Partial Cholinergic Nicotinic Agonist
Partial Cholinergic Nicotinic Agonists

Price Statistics

The NADAC for VARENICLINE 1 MG TABLET has been published 243 times since Mar 9, 2022, and over the history we have for it it has declined 94.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3544 per EA
All-time high$6.3465 (Apr 13, 2022)
All-time low$0.3161 (Sep 23, 2026)
52-week high$0.4396
52-week low$0.3161
Median price$1.2872
Average price$2.7426
Largest weekly change-51.0% (Nov 20, 2024)
Weeks tracked243
Tracking sinceMar 9, 2022

Price History

1W

N/A

1M

+12.1%

3M

+1.2%

6M

-12.0%

1Y

-19.4%

3Y

-92.2%

5Y

N/A

All

-94.3%

Last surveyed Oct 28, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VARENICLINE 1 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE 1 MG TABLET, manufactured by American Health Packaging, is $0.3544 per EA (NDC 60687064821), effective Oct 28, 2026.

How has the price of VARENICLINE 1 MG TABLET changed over time?

Over the history we have for it, the NADAC for VARENICLINE 1 MG TABLET has declined 94.3%. It has been tracked across 243 weekly CMS publications since Mar 9, 2022.

What are the highest and lowest recorded NADAC prices for VARENICLINE 1 MG TABLET?

Since Mar 9, 2022, the NADAC for VARENICLINE 1 MG TABLET has ranged from a low of $0.3161 (Sep 23, 2026) to a high of $6.3465 (Apr 13, 2022), with a median of $1.2872 per EA.

Are there cheaper alternatives to VARENICLINE 1 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VARENICLINE 1 MG CONT MONTH BX, is $0.3503 per EA — about 1% below VARENICLINE 1 MG TABLET.

Who manufactures VARENICLINE 1 MG TABLET?

VARENICLINE 1 MG TABLET (NDC 60687064821) is labeled by American Health Packaging, and CMS classifies it as a generic product.